Key Financial Data Of Reporting Company

TAKARA BIO INC. - Filing #7300711

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
19,758,000,000 JPY
43,505,000,000 JPY
19,116,000,000 JPY
Ordinary profit (loss)
549,000,000 JPY
3,405,000,000 JPY
1,598,000,000 JPY
Net assets
116,155,000,000 JPY
111,784,000,000 JPY
112,130,000,000 JPY
Total assets
125,280,000,000 JPY
121,252,000,000 JPY
123,283,000,000 JPY
Basic earnings (loss) per share
4.26
12.30
9.00
Diluted earnings per share
Equity-to-asset ratio
0.924 xbrli:pure
0.920 xbrli:pure
0.907 xbrli:pure
Net cash provided by (used in) operating activities
6,099,000,000 JPY
1,711,000,000 JPY
2,087,000,000 JPY
Net cash provided by (used in) investing activities
-396,000,000 JPY
-13,043,000,000 JPY
-10,805,000,000 JPY
Net cash provided by (used in) financing activities
-2,151,000,000 JPY
-5,233,000,000 JPY
-5,126,000,000 JPY
Cash and cash equivalents
38,223,000,000 JPY
33,171,000,000 JPY
36,065,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.